COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 154: Articles 1531-1540  | Next

Processing of Genomic RNAs by Dicer in Bat Cells Limits SARS-CoV-2 Replication
Owolabi, I. J., Karim, S., Khanal, S., Valdivia, S., Frenzel, C., Bai, F., Flynt, A. S.
10.1101/2025.01.10.632425 — Posted: 2025-01-10
Design of SARS-CoV-2 RBD Immunogens to Focus Immune Responses Towards Conserved Coronavirus Epitopes
Harris, C. M., Kapingidza, A. B., San, J. E., Christopher, J., Gavitt, T., Rhodes, B., Janowska, K., O'Donnell, C., Lindenberger, J., Huang, X., Sammour, S., Berry, M., Barr, M., Parks, R., Newman, A., Overton, M., Oguin, T., Acharya, P., Haynes, B. F., Saunders, K. O., Wiehe, K., Azoitei, M. L.
10.1101/2025.01.09.632180 — Posted: 2025-01-10
Molecular Insights into Cross-Species Spillover of Coronavirus HKU5 via ACE2 Receptor Recognition
Xia, L., Zhang, Y., Li, Y., Li, d., Zhou, Q.
10.1101/2025.01.10.632062 — Posted: 2025-01-10
Evaluating Regional Diversity in Scientific Communication: A Comparative Analysis of COVID-19 Preprints and Peer-Reviewed Publications
Kim, D. H., Jeon, K. L., You, S. C.
10.1101/2025.01.04.25319994 — Posted: 2025-01-10
Direct Health Care Costs Associated with Asthma Hospitalizations Before and During the Covid-19 Pandemic in the United States: A Nationwide Inpatient Sample Analysis.
Solanki, N., Fakhry, B., Zhang, P., Zein, J., Tsuang, W.
10.1101/2025.01.09.25320273 — Posted: 2025-01-10
Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters
da Silva Antunes, R., Fajardo-Rosas, V., Yu, E. D., Galvez, R. I., Abawi, A., Escarrega, E. A., Martinez-Perez, A., Johansson, E., Goodwin, B., Frazier, A., Dan, J. M., Crotty, S., Seumois, G., Weiskopf, D., Vijayanand, P., Sette, A.
10.1101/2025.01.08.631842 — Posted: 2025-01-10
Identification and Functional Characterization of Regulatory Variants in DPP9 Associated with COVID-19 Severity
Farah, G., Torres, M., Henches, L., Aschard, H., Ghosn, J., Duval, X., Milieu Interieur Consortium, , French COVID Cohort Study Group, , Rihet, P., Spicuglia, S., Marquet, S.
10.1101/2025.01.07.631679 — Posted: 2025-01-09
APMAT analysis reveals the association between CD8 T cell receptors, cognate antigen, and T cell phenotype and persistence
Xie, J., Chen, D. G., Chour, W., Ng, R. H., Zhang, R., Yuan, D., Choi, J., McKasson, M., Troisch, P., Smith, B., Jones, L., Webster, A., Rasheed, Y., Li, S., Edmark, R., Hong, S., Murray, K. M., Logue, J. K., Franko, N. M., Lausted, C. G., Piening, B., Algren, H., Wallick, J., Magis, A. T., Watanabe, K., Mease, P., Greenberg, P. D., Chu, H., Goldman, J. D., Su, Y., Heath, J. R.
10.1101/2025.01.08.631993 — Posted: 2025-01-09
Quantifying the spatiotemporal dynamics of the first two epidemic waves of SARS-CoV-2 infections in the United States
Lopes, R., Grubaugh, N. D., Cohen, T., Swartwood, N. A., Menzies, N. A., Chitwood, M. H., Klaassen, F., Warren, J. L., Salomon, J. A., Lan, Y.
10.1101/2025.01.08.24319433 — Posted: 2025-01-08
Protocol: A Systematic Review of Multi-Sectoral Coordination during the COVID-19 Pandemic Practices, Challenges, and Recommendations for Future Preparedness
Okello, J. S., Nyerere, J. O., Ginindza, T.
10.1101/2025.01.08.25320177 — Posted: 2025-01-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).